Cargando…
COVID-19 in multiple sclerosis patients and risk factors for severe infection
Multiple sclerosis (MS) patients have been considered a higher-risk population for COVID-19 due to the high prevalence of disability and disease-modifying therapy use; however, there is little data identifying clinical characteristics of MS associated with worse COVID-19 outcomes. Therefore, we cond...
Autores principales: | Chaudhry, Farhan, Bulka, Helena, Rathnam, Anirudha S., Said, Omar M., Lin, Jia, Lorigan, Holly, Bernitsas, Eva, Rube, Jacob, Korzeniewski, Steven J., Memon, Anza B., Levy, Phillip D., Schultz, Lonni, Javed, Adil, Lisak, Robert, Cerghet, Mirela |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7834402/ https://www.ncbi.nlm.nih.gov/pubmed/32980780 http://dx.doi.org/10.1016/j.jns.2020.117147 |
Ejemplares similares
-
Review of the COVID-19 Risk in Multiple Sclerosis
por: Chaudhry, Farhan, et al.
Publicado: (2021) -
Neuromyelitis Optica in a Young Woman With Tuberous Sclerosis: Is
There an Association?
por: Elkhooly, Mahmoud, et al.
Publicado: (2022) -
Effect of Obesity on Retinal Integrity in African Americans and Caucasian Americans With Relapsing Multiple Sclerosis
por: Rube, Jacob, et al.
Publicado: (2021) -
Long-term safety of rituximab induced peripheral B-cell depletion in autoimmune neurological diseases
por: Memon, Anza B., et al.
Publicado: (2018) -
Value of terminal latency index and sensory electrophysiology in idiopathic and diabetic chronic inflammatory demyelinating polyradiculoneuropathy
por: Memon, Anza B., et al.
Publicado: (2019)